1,034 reports of this reaction
2.0% of all ANASTROZOLE TABLETS reports
#7 most reported adverse reaction
DYSPNOEA is the #7 most commonly reported adverse reaction for ANASTROZOLE TABLETS, manufactured by Avet Pharmaceuticals Inc. There are 1,034 FDA adverse event reports linking ANASTROZOLE TABLETS to DYSPNOEA. This represents approximately 2.0% of all 50,885 adverse event reports for this drug.
Patients taking ANASTROZOLE TABLETS who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is a less commonly reported adverse event for ANASTROZOLE TABLETS, but still significant enough to appear in the safety profile.
In addition to dyspnoea, the following adverse reactions have been reported for ANASTROZOLE TABLETS:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 1,034 FDA reports for ANASTROZOLE TABLETS. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 2.0% of all adverse event reports for ANASTROZOLE TABLETS, making it a notable side effect.
If you experience dyspnoea while taking ANASTROZOLE TABLETS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.